James P. Rizzi

Person

Waterford, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...
- Patent number 10,669,269
- Issue date Jun 2, 2020
- Array Biopharma Inc.
- Mark Laurence Boys
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...
- Patent number 9,809,590
- Issue date Nov 7, 2017
- Array Biopharma Inc.
- Mark Laurence Boys
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...
- Patent number 9,174,981
- Issue date Nov 3, 2015
- Array Biopharma Inc.
- Mark Laurence Boys
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...
- Patent number 8,841,455
- Issue date Sep 23, 2014
- Array Biopharma Inc.
- Mark Laurence Boys
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
P38 inhibitors and methods of use thereof
- Patent number 8,518,983
- Issue date Aug 27, 2013
- Array Biopharma Inc.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibi...
- Patent number 8,138,181
- Issue date Mar 20, 2012
- Array Biopharma Inc.
- Shelley Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors and methods of use thereof
- Patent number 8,044,083
- Issue date Oct 25, 2011
- Array Biopharma Inc.
- Robert Groneberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors and methods of use thereof
- Patent number 8,039,639
- Issue date Oct 18, 2011
- Array Biopharma Inc.
- Robert Groneberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
P38 inhibitors and methods of use thereof
- Patent number 8,026,233
- Issue date Sep 27, 2011
- Array Biopharma Inc.
- Mark C. Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
P38 inhibitors and methods of use thereof
- Patent number 8,017,641
- Issue date Sep 13, 2011
- Array Biopharma Inc.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
P38 inhibitors and methods of use thereof
- Patent number 7,799,782
- Issue date Sep 21, 2010
- Array Biopharma Inc.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
P38 inhibitors and methods of use thereof
- Patent number 7,521,447
- Issue date Apr 21, 2009
- Array Biopharma Inc.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
P38 inhibitors and methods of use thereof
- Patent number 7,135,575
- Issue date Nov 14, 2006
- Array BioPharma, Inc.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
- Patent number 6,605,634
- Issue date Aug 12, 2003
- Amgen, Inc.
- Jeffery A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors
- Patent number 6,509,337
- Issue date Jan 21, 2003
- Pfizer Inc.
- Anthony Piscopio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
- Patent number 6,440,973
- Issue date Aug 27, 2002
- Amgen Inc.
- Jeffery A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulfonylamino hydroxamic acid derivatives
- Patent number 6,380,219
- Issue date Apr 30, 2002
- Pfizer Inc.
- Ralph P. Robinson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which inhibit tryptase activity
- Patent number 6,362,216
- Issue date Mar 26, 2002
- Array Biopharma Inc.
- Laurence E. Burgess
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide bridging compounds that inhibit tryptase activity
- Patent number 6,221,914
- Issue date Apr 24, 2001
- Array Biopharma Inc.
- Laurence E. Burgess
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
- Patent number 6,180,643
- Issue date Jan 30, 2001
- Amgen Inc.
- Jeffery A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulfonylamino hydroxamic acid derivatives
- Patent number 6,147,074
- Issue date Nov 14, 2000
- Pfizer Inc.
- Ralph P. Robinson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic sulfone derivatives
- Patent number 6,077,864
- Issue date Jun 20, 2000
- Pfizer Inc.
- Laurence Edward Burgess
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulfonylamino hydroxamic acid derivatives
- Patent number 5,994,351
- Issue date Nov 30, 1999
- Pfizer Inc.
- Ralph P. Robinson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic sulfone derivatives
- Patent number 5,883,131
- Issue date Mar 16, 1999
- Pfizer Inc.
- Laurence E. Burgess
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulfonylamino hydroxamic acid derivatives
- Patent number 5,863,949
- Issue date Jan 26, 1999
- Pfizer Inc.
- Ralph P. Robinson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors
- Patent number 5,861,510
- Issue date Jan 19, 1999
- Pfizer Inc.
- Anthony Piscopio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazolidinedione hypoglycemic agents
- Patent number 5,223,522
- Issue date Jun 29, 1993
- Pfizer Inc.
- David A. Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazolidinedione hypoglycemic agents
- Patent number 5,120,754
- Issue date Jun 9, 1992
- Pfizer Inc.
- David A. Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazolidinedione hypoglycemic agents
- Patent number 5,061,717
- Issue date Oct 29, 1991
- Pfizer Inc.
- David A. Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclicguanidines as 5HT.sub.3 antagonists
- Patent number 4,963,689
- Issue date Oct 16, 1990
- Pfizer Inc.
- Arthur A. Nagel
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE...
- Publication number 20180086758
- Publication date Mar 29, 2018
- ARRAY BIOPHARMA INC.
- Mark Laurence Boys
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE...
- Publication number 20160002232
- Publication date Jan 7, 2016
- ARRAY BIOPHARMA INC.
- Mark Laurence Boys
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-]PYRIDINE-3-CARBOXAMIDE...
- Publication number 20130274244
- Publication date Oct 17, 2013
- Mark Laurence Boys
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide...
- Publication number 20120258952
- Publication date Oct 11, 2012
- ARRAY BIOPHARMA INC.
- Mark Laurence Boys
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KINASE INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20110124878
- Publication date May 26, 2011
- ARRAY BIOPHARMA INC.
- Robert Groneberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALKYLSULFONAMIDE-SUBSTITUTED TRIAZOLES AS MATRIX METALLOPROTEASE IN...
- Publication number 20100234378
- Publication date Sep 16, 2010
- ARRAY BIOPHARMA INC.
- Andrew M. Fryer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBI...
- Publication number 20100144751
- Publication date Jun 10, 2010
- ARRAY BIOPHARMA INC.
- Fredrik P. Marmsater
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBI...
- Publication number 20100029633
- Publication date Feb 4, 2010
- ARRAY BIOPHARMA INC.
- Shelley Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20090149443
- Publication date Jun 11, 2009
- Mark C. Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20090149459
- Publication date Jun 11, 2009
- ARRAY BIOPHARMA INC.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20090143422
- Publication date Jun 4, 2009
- ARRAY BIOPHARMA INC.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20090136596
- Publication date May 28, 2009
- ARRAY BIOPHARMA INC.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors And Methods Of Use Thereof
- Publication number 20090023795
- Publication date Jan 22, 2009
- Robert Groneberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 inhibitors and methods of use thereof
- Publication number 20060264431
- Publication date Nov 23, 2006
- Array BioPharma Inc.
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 inhibitors and methods of use thereof
- Publication number 20040192653
- Publication date Sep 30, 2004
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 inhibitors and methods of use thereof
- Publication number 20040180896
- Publication date Sep 16, 2004
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 inhibitors and methods of use thereof
- Publication number 20040176325
- Publication date Sep 9, 2004
- Mark Munson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
- Publication number 20030096819
- Publication date May 22, 2003
- Amgen Inc.
- Jeffery A. Zablocki
- C07 - ORGANIC CHEMISTRY

James P. Rizzi

Person

Patents Grantslast 30 patents

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide...

P38 inhibitors and methods of use thereof

Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibi...

Kinase inhibitors and methods of use thereof

Kinase inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents

Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors

Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents

Arylsulfonylamino hydroxamic acid derivatives

Compounds which inhibit tryptase activity

Sulfonamide bridging compounds that inhibit tryptase activity

Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents

Arylsulfonylamino hydroxamic acid derivatives

Cyclic sulfone derivatives

Arylsulfonylamino hydroxamic acid derivatives

Cyclic sulfone derivatives

Arylsulfonylamino hydroxamic acid derivatives

Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors

Thiazolidinedione hypoglycemic agents

Thiazolidinedione hypoglycemic agents

Thiazolidinedione hypoglycemic agents

Heterocyclicguanidines as 5HT.sub.3 antagonists

Patents Applicationslast 30 patents

SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE...

SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE...

SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-]PYRIDINE-3-CARBOXAMIDE...

Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide...

KINASE INHIBITORS AND METHODS OF USE THEREOF

ALKYLSULFONAMIDE-SUBSTITUTED TRIAZOLES AS MATRIX METALLOPROTEASE IN...

IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBI...

IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBI...

P38 INHIBITORS AND METHODS OF USE THEREOF

P38 INHIBITORS AND METHODS OF USE THEREOF

P38 INHIBITORS AND METHODS OF USE THEREOF

P38 INHIBITORS AND METHODS OF USE THEREOF

Kinase Inhibitors And Methods Of Use Thereof

P38 inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

P38 inhibitors and methods of use thereof

Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents